OneMedNet Corp 8-K

What Happened OneMedNet Corporation (ONMD) filed an 8-K on December 23, 2025 reporting the outcomes of its December 17, 2025 Annual Meeting of Stockholders and a subsequent board committee appointment. At the virtual Annual Meeting, 40,710,355 shares were represented — 79.87% of outstanding shares, constituting a quorum. Stockholders elected two Class II directors for three-year terms and ratified the appointment of Withum Smith+Brown, PC as the company’s independent registered public accounting firm. On December 23, 2025 the Board appointed Dr. Kenneth Alleyne to the Compensation Committee, replacing Jair Clarke whose board term expired at the Annual Meeting.

Key Details

• Meeting participation: 40,710,355 shares represented (79.87% of shares entitled to vote).
• Director elections (Class II, terms to 2028):
  • Robert Golden — For: 30,232,405; Withhold: 118,122; Broker non‑votes: 10,359,828.
  • Andrew Zeinfeld — For: 30,133,929; Withhold: 216,598; Broker non‑votes: 10,359,828.
• Auditor ratification: Withum Smith+Brown, PC ratified — For: 40,698,469; Against: 3,395; Abstain: 8,491.
• Board committee change: Dr. Kenneth Alleyne appointed to the Compensation Committee on Dec 23, 2025, replacing Jair Clarke.

Why It Matters These results confirm the company’s board composition and continuity in its external audit oversight, both important for corporate governance and financial reporting stability. The high quorum (nearly 80%) indicates broad shareholder participation; the recorded broker non‑votes reflect shares present but not voted on director elections. The appointment of Dr. Kenneth Alleyne to the Compensation Committee affects who will oversee executive pay and related governance matters going forward.